Tax Dodger Apple Te...
Health Care: Health Services
Boston Scientific Inc. (BSX: NYSE)
$9.23 -0.02 | -0.22%
05/21/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 9.25 |
| 52 Week High | 9.38 |
| 52 Week Low | 4.79 |
| Avg. Daily Vol. (Mil) | 18.48 |
| Beta (3 year) | 1.24 |
| Share Related Items | |
| Mkt Cap (Mil) | 12,479.10 |
| Shares Out (Mil) | 1,349.09 |
| Float (Mil) | 1,338.25 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 0.65 |
| Total Debt / Equity | 0.65 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.75 |
| Price/Book | 1.92 |
| Price/Cash Flow | -3.30 |
| Per Share Data | |
| Earnings | -3.23 |
| Sales | 5.30 |
| Book Value | 4.82 |
| Cash Flow | -2.77 |
| Business Summary | |
|---|---|
| Boston Scientific, Inc., is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. | |
| General Information | |
| One Boston Scientific Place
Natick, MA 01760-1537 |
|
| www.bsci.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 24000 | |
| CEO: Mr. Michael F. Mahoney | |
| Short Interest | |
| Current Month (Mil) | 33.74 |
| Previous Month (Mil) | 34.41 |
| Short Interest Ratio (Days) | 1.80 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -26.40 |
| Return on Investments | -41.00 |
| Profitability | |
| Gross Margin | 71.80 |
| EBIT Margin | -61.10 |
| Profit Margin | -61.90 |
Portfolios with BSX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorMost-Active Stocks for the ...
- ContributorMost-Active Stocks for the ...
- Contributor10 Profitable and Oversold ...
- Userjennydog
- ProLeon Cooperman - Omega Advi...
- ContributorHealth Care Stocks Bought a...
- Contributor6 Stocks Purchased by Billi...
- Contributor8 Health Care Stocks Inside...
- UserPFE
Latest BSX Headlines from TheStreet
- Boston Scientific Inc. (BSX): Today's Featured Health Services Winner 05.20.13 | 05:05 pm
- Cramer's Top Stock Picks: BSX BAX FB 05.18.13 | 06:05 am
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 05.17.13 | 08:05 pm
- 'Mindless' Picks: RIM, Molycorp
05.14.13 | 02:05 pm - 5 Stocks Boosting The Health Services Industry Higher 05.13.13 | 01:05 pm
- Analysts' Actions: MU BSX CVC FRX 05.10.13 | 08:05 am
- Cramer's 'Mad Money' Recap: Looking for Real Leaders 05.09.13 | 08:05 pm
- Boston Scientific Inc. (BSX): Today's Featured Health Services Winner 05.09.13 | 05:05 pm
- 5 Health Services Stocks Nudging The Industry Higher 05.09.13 | 01:05 pm
- 5 Stocks Moving The Health Services Industry Upward 04.25.13 | 01:04 pm
Press Releases for BSX
- Boston Scientific Long Term Data Demonstrate Bronchial Thermoplasty Treatment Benefits Persist Out To Five Years In Patients With Severe Asthma - PR Newswire 05.21.13 | 11:05 am
- OrbusNeich Seizes Boston Scientific Stents In Germany As Part Of Patent Infringement Proceedings - PR Newswire 05.21.13 | 05:05 am
- Boston Scientific Presents Clinical Data At Digestive Disease Week® - PR Newswire 05.17.13 | 09:05 am
- Boston Scientific Schedule Of Major Events And Presentations At EuroPCR 2013 - PR Newswire 05.17.13 | 03:05 am
- First Patient Enrolled In Boston Scientific Randomized Study Comparing WallFlex® Biliary RX Stent To Absence Of Biliary Drainage In Patients With Pancreatic Or Periampullary Cancers - PR Newswire 05.15.13 | 12:05 pm
- OrbusNeich Obtains Additional Preliminary Injunction Against Boston Scientific In Germany - PR Newswire 05.14.13 | 03:05 am
- Boston Scientific Receives CE Mark Approval For The Rhythmiaâ¿¢ Mapping System - PR Newswire 05.10.13 | 09:05 am
- New Four-Year Data From Boston Scientific Demonstrated WATCHMAN® Device Was Superior To Warfarin For Mortality And Primary Efficacy In Patients With Atrial Fibrillation In Long Term Follow-Up Of The PROTECT AF Trial - PR Newswire 05.09.13 | 12:05 pm
- Boston Scientific To Participate In The Bank Of America Merrill Lynch 2013 Healthcare Conference - PR Newswire 05.08.13 | 09:05 am
- Boston Scientific Completes First-In-Human Clinical Trial Of The IntellaTip MiFiâ¿¢ XP Ablation Catheter For Patients With Type 1 Atrial Flutter - PR Newswire 05.06.13 | 08:05 am
Partner Headlines for BSX
- Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying - Benzinga 03.09.13 | 02:03 pm
- Olympus: climbing a mountain - Financial Times 02.12.13 | 12:02 pm
- St. Jude to Repurchase $1B Shares - Analyst Blog - Zacks 11.30.12 | 05:11 pm
- After Hours Most Active for Nov 20, 2012 : BAC, HPQ, IHG, QQQ, ONNN, BX, BSX, GNW, MSFT, CSTR, SPLS, PBCT - NASDAQ 11.20.12 | 09:11 pm
- Medtronic Earnings Solid, Guidance Cautious - Investor's Business Daily 11.20.12 | 04:11 pm
- St. Jude Remains Neutral - Analyst Blog - Zacks 11.13.12 | 06:11 pm
- Greatbatch Beats Ests, Profits Dip - Analyst Blog - Zacks 10.26.12 | 05:10 pm
- Stryker to Expand, Aims Surpass - Analyst Blog - Zacks 10.19.12 | 04:10 pm
- Obamacare Can Learn From These Healthcare Stocks - Seeking Alpha 10.19.12 | 09:10 am
- Boston Scientific: Earnings Decline Coupled With A Weak Market Outlook - Seeking Alpha 10.19.12 | 09:10 am
